<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Bras Pneumol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Bras Pneumol</journal-id>
      <journal-id journal-id-type="publisher-id">jbpneu</journal-id>
      <journal-title-group>
        <journal-title>Jornal Brasileiro de Pneumologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1806-3713</issn>
      <issn pub-type="epub">1806-3756</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Pneumologia e Tisiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26982044</article-id>
      <article-id pub-id-type="pmc">4805390</article-id>
      <article-id pub-id-type="doi">10.1590/S1806-37562016000000193</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Relato De Caso</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Angiosarcoma of the lung</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Grafino</surname>
            <given-names>M&#xF3;nica</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alves</surname>
            <given-names>Paula</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Almeida</surname>
            <given-names>Margarida Mendes</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Garrido</surname>
            <given-names>Patr&#xED;cia</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hasmucrai</surname>
            <given-names>Direndra</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Teixeira</surname>
            <given-names>Encarna&#xE7;&#xE3;o</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sotto-Mayor</surname>
            <given-names>Renato</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>. Departamento do T&#xF3;rax, Servi&#xE7;o de Pneumologia, Hospital de Dia de Pneumologia Oncol&#xF3;gica, Centro Hospitalar Lisboa Norte, EPE, Lisboa, Portugal</aff>
      <aff id="aff2"><label>2</label>. Servi&#xE7;o de Anatomia Patol&#xF3;gica, Centro Hospitalar Lisboa Norte, EPE, Lisboa, Portugal</aff>
      <author-notes>
        <corresp id="c01">Correspondence to: M&#xF3;nica de Jesus Marques Grafino. Centro Hospitalar Lisboa Norte, EPE; Hospital Pulido Valente, Hospital de Dia de Pneumologia Oncol&#xF3;gica, Alameda das Linhas de Torres, 117, 1769-001, Lisboa, Portugal. Tel.: 351 96 1228496. E-mail: <email>mgrafino@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jan-Feb</season>
        <year>2016</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jan-Feb</season>
        <year>2016</year>
      </pub-date>
      <volume>42</volume>
      <issue>1</issue>
      <fpage>68</fpage>
      <lpage>70</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>8</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Angiosarcoma is a rare malignant vascular tumor. Pulmonary involvement is usually attributable to metastasis from other primary sites, primary pulmonary angiosarcoma therefore being quite uncommon. We report a case of angiosarcoma with pulmonary involvement, probably primary to the lung, which had gone untreated for more than two years. We describe this rare neoplasm and its growth, as well as the extensive local invasion and hematogenous metastasis at presentation. We also discuss its poor prognosis.</p>
      </abstract>
      <kwd-group>
        <kwd>Hemangiosarcoma</kwd>
        <kwd>Lung neoplasms</kwd>
        <kwd>Sarcoma</kwd>
      </kwd-group>
      <counts>
        <fig-count count="6"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="11"/>
        <page-count count="3"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Angiosarcoma is a malignant endothelial cell tumor of vascular or lymphatic origin and accounts for approximately 2% of all soft tissue sarcomas.<sup>(</sup>
<xref rid="B01" ref-type="bibr">1</xref>
<sup>)</sup> The most common primary sites are the skin and the subcutaneous tissue of the head and neck.<sup>(</sup>
<xref rid="B02" ref-type="bibr">2</xref>
<sup>)</sup> Pulmonary involvement is almost always metastatic.<sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>)</sup> Primary pulmonary angiosarcoma is extremely rare, only a few cases having been reported.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 78-year-old female nonsmoker had previously been examined, a CT scan of the chest having shown a left upper lobe pulmonary mass (<xref ref-type="fig" rid="f01">Figure 1</xref>A). At that time, she underwent bronchoscopy with BAL and bronchial biopsy. The BAL fluid and the biopsy sample were both negative for neoplastic tissue. She subsequently dropped out of follow-up. Two years later, she was referred to our hospital with a six-month history of shortness of breath, dry cough, and weight loss. A chest X-ray and a chest CT scan (without contrast) identified a 10 &#xD7; 7 cm lesion in the left upper lobe without forming cleavage plans with the aorta and the pulmonary artery (Figures 1B and 1C), with a small left pleural effusion and small mediastinal lymph nodes. An <sup>18</sup>F-fluorodeoxyglucose positron emission tomography-CT (FDG PET-CT) scan (<xref ref-type="fig" rid="f01">Figure 1</xref>D) showed increased metabolic activity in many organs, greatest in the mass in the upper left lobe, the maximum standardized uptake value (SUVmax) of which was 22. Metabolic activity was also increased in the mediastinal lymph nodes (SUVmax = 7), as well as in the right and left suprarenal glands (SUVmax = 16 for both); the aortic lumbar lymph nodes (SUVmax = 11); and the right inguinal lymph node (SUVmax = 10). In addition, there was a mesenteric focus, together with subcutaneous tissue nodes and multiple locations in bone.</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>Evolution of angiosarcoma in a 78-year-old female nonsmoker: in A, initial CT scan of the chest showing a left upper lobe pulmonary mass; in B and C, CT scans of the chest, obtained two years later, showing a 10 &#xD7; 7 cm lesion in the left upper lobe, with a small left pleural effusion and small mediastinal lymph nodes; in D, an <sup>18</sup>F-fluorodeoxyglucose positron emission tomography-CT scan showing increased metabolic activity in many organs, greatest in the mass in the upper left lobe.</title></caption><graphic xlink:href="1806-3713-jbpneu-42-01-00068-gf01"/></fig>
</p>
      <p>The bronchoscopic examination revealed a mass occluding the left upper lobe bronchus (<xref ref-type="fig" rid="f02">Figure 2</xref>), and a bronchoscopic biopsy was performed. Before the results of the tissue sample examination had been obtained, she developed right hemiparesis and a new subcutaneous nodule arose. A CT scan showed multiple brain lesions. She was started on corticosteroids. However, she showed no clinical improvement and brain radiotherapy was proposed.</p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2.</label><caption><title>Photograph of a mass occluding the left upper lobe bronchus.</title></caption><graphic xlink:href="1806-3713-jbpneu-42-01-00068-gf02"/></fig>
</p>
      <p>The histological examination of the biopsy specimen showed a soft-tissue neoplasm with a sheet-like or enclosing cleft arrangement of spindle and epithelioid cells with prominent nucleoli, with some multinucleation; mitotic figures were conspicuous, as were extensive necrosis and hemorrhage (<xref ref-type="fig" rid="f03">Figure 3</xref>A). Immunohistochemical staining of the tumor specimen revealed that it was strongly positive for CD31 (<xref ref-type="fig" rid="f03">Figure 3</xref>B), factor VIII-related antigen (<xref ref-type="fig" rid="f03">Figure 3</xref>C), and vimentin; weakly positive for the nuclear transcription factor Fli-1 and cytokeratin AE1/AE3; and negative for CD34, desmin, and smooth muscle actin. Therefore, the histology and immunohistochemistry were both consistent with epithelioid angiosarcoma.</p>
      <p>
<fig id="f03" orientation="portrait" position="float"><label>Figure 3.</label><caption><title>Histological examination of the biopsy specimen: in A, extensive necrosis and hemorrhage; in B, immunohistochemical staining for CD31; in C, immunohistochemical staining for factor VIII-related antigen.</title></caption><graphic xlink:href="1806-3713-jbpneu-42-01-00068-gf03"/></fig>
</p>
      <p>Two weeks after the histologic diagnosis had been made, the patient died. Her death was attributed to the progression of the disease, the brain metastases in particular.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Angiosarcoma in the lung usually represents metastasis from another primary site. Nevertheless, we believe that the case presented here was one of primary pulmonary angiosarcoma. The patient had a two-year evolution of a pulmonary mass that had gone unmonitored and untreated for more than two years. It seems apparent that the previous lesion corresponded to the pulmonary angiosarcoma that evolved and disseminated during that time. This case report also documents the behavior of a primary pulmonary angiosarcoma, which is characterized by insidious growth with extensive local invasion and hematogenous metastasis.<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>)</sup>
</p>
      <p>Early diagnosis of pulmonary angiosarcoma is not common, because of its rarity and the low index of suspicion. According to data in the literature, the average age of pulmonary angiosarcoma patients is 55.9 years (range, 23.0-82.0 years) and males are more often affected than are female.<sup>(</sup>
<xref rid="B05" ref-type="bibr">5</xref>
<sup>)</sup> Patients usually present nonspecific respiratory symptoms that include hemoptysis, cough, dyspnea, chest pain, and weight loss. On CT scans, primary angiosarcoma can be multifocal or can manifest as solitary lesions. <sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">6</xref>
<sup>,</sup>
<xref rid="B07" ref-type="bibr">7</xref>
<sup>)</sup> Imaging with PET can be useful in the diagnosis, staging,<sup>(</sup>
<xref rid="B08" ref-type="bibr">8</xref>
<sup>)</sup> and follow-up of patients with angiosarcoma. <sup>(</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>)</sup> In the case presented here, the FDG PET-CT scan confirmed its usefulness in identifying the regions and systems involved.</p>
      <p>Biopsy and immunohistochemical analysis are essential for the diagnosis of angiosarcoma. The histological features can vary within and among cases. Abnormal, pleomorphic, malignant endothelial cells constitute the hallmark of angiosarcoma. Those cells can be rounded, polygonal, or fusiform, with or without an epithelioid appearance. In well-differentiated areas, abnormal endothelial cells form functioning vascular sinusoidal channels that are continuous with normal vascular channels. In patients with progressively more aggressive disease, the architecture becomes more chaotic, with less clearly defined vascular spaces. In poorly differentiated areas, the malignant endothelial cells form continuous monolayers, usually with an epithelioid morphology. An angiosarcoma typically expresses endothelial markers including factor VIII-related antigen, CD34, CD31, and Fli-1. Among those markers, factor VIII-related antigen is the most specific but the least sensitive. Positivity for CD31 is relatively specific and extremely sensitive, being detected in approximately 90% of the cases. In approximately 30% of the cases, angiosarcoma expresses cytokeratin.<sup>(</sup>
<xref rid="B10" ref-type="bibr">10</xref>
<sup>)</sup>
</p>
      <p>Due to the rarity of angiosarcoma, no standardized therapy regimen has been established, especially for primary pulmonary angiosarcoma. Patients with pulmonary angiosarcoma have been treated with radiotherapy,<sup>(</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>,</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>)</sup> surgical resection,<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>)</sup> immunotherapy,<sup>(4,6,11) </sup>chemotherapy,<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">6</xref>
<sup>,</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>)</sup> or a combination of those.<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">6</xref>
<sup>,</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>,</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>)</sup> Although none of those treatments have been shown to be effective, there have been reports of effective treatments for the condition,<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>,</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>)</sup> especially in cases of localized disease. It has been proposed that the most effective treatment is surgery, which should be considered as early as possible for resectable tumors.<sup>(</sup>
<xref rid="B05" ref-type="bibr">5</xref>
<sup>)</sup> However, neoplasms are often inoperable at the time of diagnosis. Multimodality therapy, such as the combination of radiotherapy and immunotherapy (recombinant interleukin-2)<sup>(</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>)</sup> and that of surgery and chemotherapy,<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>)</sup> has also proven to be effective. Chemotherapy with gemcitabine and docetaxel has been reported to produce a complete radiographic response.<sup>(</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>)</sup>
</p>
      <p>The prognosis of pulmonary angiosarcoma is poor, mortality within the first few months after clinical presentation, as occurred in the case presented here, approaching 100%.<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>-</sup>
<xref rid="B07" ref-type="bibr">7</xref>
<sup>)</sup>
</p>
      <p>Angiosarcoma is a rare malignant neoplasm, and only a few dozen cases of primary pulmonary angiosarcoma have been reported in the literature. It is a diagnostic challenge for clinicians and pathologists. A high index of suspicion is essential to its early diagnosis and could improve its poor prognosis. </p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>Study carried out in the Centro Hospitalar Lisboa Norte, EPE, Lisboa, Portugal.</p>
      </fn>
      <fn id="fn02" fn-type="supported-by">
        <p>Financial support: None.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Young</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Woll</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Angiosarcoma</article-title>
          <source>Lancet Oncol</source>
          <year>2010</year>
          <volume>11</volume>
          <issue>10</issue>
          <fpage>983</fpage>
          <lpage>991</lpage>
          <pub-id pub-id-type="doi">10.1016/S1470-2045(10)70023-1</pub-id>
          <pub-id pub-id-type="pmid">20537949</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Penel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Marr&#xE9;aud</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Robin</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Hohenberger</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Angiosarcoma: state of the art and perspectives</article-title>
          <source>Crit Rev Oncol Hematol</source>
          <year>2011</year>
          <volume>80</volume>
          <issue>2</issue>
          <fpage>257</fpage>
          <lpage>263</lpage>
          <pub-id pub-id-type="doi">10.1016/j.critrevonc.2010.10.007</pub-id>
          <pub-id pub-id-type="pmid">21055965</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patel</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ryu</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Angiosarcoma in the lung</article-title>
          <source>Chest</source>
          <year>1993</year>
          <volume>103</volume>
          <issue>5</issue>
          <fpage>1531</fpage>
          <lpage>1535</lpage>
          <pub-id pub-id-type="doi">10.1378/chest.103.5.1531</pub-id>
          <pub-id pub-id-type="pmid">8486039</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>YB</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>XQ</given-names>
            </name>
            <name>
              <surname>Ling</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Angiosarcoma of the lung: 2 cases report and literature reviewed</article-title>
          <source>Lung Cancer</source>
          <year>2010</year>
          <volume>70</volume>
          <issue>3</issue>
          <fpage>352</fpage>
          <lpage>356</lpage>
          <pub-id pub-id-type="doi">10.1016/j.lungcan.2010.09.002</pub-id>
          <pub-id pub-id-type="pmid">20952087</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimabukuro</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Yatera</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Noguchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kawanami</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Iwanami</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Primary Pulmonary Angiosarcoma Presenting with Hemoptysis and Ground-Glass Opacity: A Case Report and Literature Review</article-title>
          <source>Tohoku J Exp Med</source>
          <year>2015</year>
          <volume>237</volume>
          <issue>4</issue>
          <fpage>273</fpage>
          <lpage>278</lpage>
          <pub-id pub-id-type="doi">10.1620/tjem.237.273</pub-id>
          <pub-id pub-id-type="pmid">26582434</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Judy</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Predina</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Mittal</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Deshpande</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Singhal</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Metastatic Primary Pulmonary Angiosarcoma</article-title>
          <source>Surg Sci</source>
          <year>2011</year>
          <volume>2</volume>
          <issue>3</issue>
          <fpage>130</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="doi">10.4236/ss.2011.23026</pub-id>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozcelik</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Onat</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yaldiz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ozcelik</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Primary epithelioid angiosarcoma of the lung presenting as pulmonary hemorrhage</article-title>
          <source>Asian Cardiovasc Thorac Ann</source>
          <year>2006</year>
          <volume>14</volume>
          <issue>1</issue>
          <fpage>69</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1177/021849230601400118</pub-id>
          <pub-id pub-id-type="pmid">16432125</pub-id>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Treglia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cardillo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Graziano</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>A rare case of primary pulmonary epithelioid angiosarcoma detected by (18)F-FDG PET/CT</article-title>
          <source>Clin Nucl Med</source>
          <year>2014</year>
          <volume>39</volume>
          <issue>5</issue>
          <fpage>450</fpage>
          <lpage>452</lpage>
          <pub-id pub-id-type="doi">10.1097/RLU.0b013e318292f3b3</pub-id>
          <pub-id pub-id-type="pmid">23657141</pub-id>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Glaros</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Michael</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Reisman</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Complete radiographic response of primary pulmonary angiosarcomas following gemcitabine and taxotere</article-title>
          <source>Lung Cancer</source>
          <year>2008</year>
          <volume>61</volume>
          <issue>1</issue>
          <fpage>131</fpage>
          <lpage>136</lpage>
          <pub-id pub-id-type="doi">10.1016/j.lungcan.2007.12.006</pub-id>
          <pub-id pub-id-type="pmid">18243404</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Travis</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Brambilla</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Muller-Hermelink</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>CC</given-names>
            </name>
          </person-group>
          <source>World Health Organization Classification of Tumours.Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart</source>
          <publisher-loc>IARC Press</publisher-loc>
          <publisher-name>Lyon</publisher-name>
          <year>2004</year>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kojima</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ushijima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yoshinaga</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kitaoka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Suga</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Successful treatment of primary pulmonary angiosarcoma</article-title>
          <source>Chest</source>
          <year>2003</year>
          <volume>124</volume>
          <issue>6</issue>
          <fpage>2397</fpage>
          <lpage>2400</lpage>
          <pub-id pub-id-type="doi">10.1378/chest.124.6.2397</pub-id>
          <pub-id pub-id-type="pmid">14665530</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="S01" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Relato De Caso</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Angiossarcoma pulmonar</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Grafino</surname>
            <given-names>M&#xF3;nica</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alves</surname>
            <given-names>Paula</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Almeida</surname>
            <given-names>Margarida Mendes de</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Garrido</surname>
            <given-names>Patr&#xED;cia</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hasmucrai</surname>
            <given-names>Direndra</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Teixeira</surname>
            <given-names>Encarna&#xE7;&#xE3;o</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sotto-Mayor</surname>
            <given-names>Renato</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>. Departamento do T&#xF3;rax, Servi&#xE7;o de Pneumologia, Hospital de Dia de Pneumologia Oncol&#xF3;gica, Centro Hospitalar Lisboa Norte, EPE, Lisboa, Portugal</aff>
      <aff id="aff02"><label>2</label>. Servi&#xE7;o de Anatomia Patol&#xF3;gica, Centro Hospitalar Lisboa Norte, EPE, Lisboa, Portugal</aff>
      <author-notes>
        <corresp id="c1">Endere&#xE7;o para correspond&#xEA;ncia: M&#xF3;nica de Jesus Marques Grafino. Centro Hospitalar Lisboa Norte, EPE; Hospital Pulido Valente, Hospital de Dia de Pneumologia Oncol&#xF3;gica, Alameda das Linhas de Torres, 117, 1769-001, Lisboa, Portugal. Tel.: 351 96 1228496. E-mail: <email>mgrafino@gmail.com</email></corresp>
      </author-notes>
      <abstract>
        <p>O angiosarcoma &#xE9; um tumor vascular maligno. O envolvimento pulmonar &#xE9; geralmente atribu&#xED;do &#xE0; met&#xE1;stase de outros s&#xED;tios prim&#xE1;rios, sendo o angiossarcoma pulmonar prim&#xE1;rio extremamente raro. Relatamos um caso de angiossarcoma com envolvimento pulmonar, provavelmente prim&#xE1;rio no pulm&#xE3;o com mais de dois anos de evolu&#xE7;&#xE3;o. Descrevemos seu crescimento e sua extensa invas&#xE3;o local e hematog&#xEA;nica na apresenta&#xE7;&#xE3;o. Documentamos ainda seu mau progn&#xF3;stico.</p>
      </abstract>
      <kwd-group>
        <kwd>Hemangiossarcoma</kwd>
        <kwd>Neoplasias pulmonares</kwd>
        <kwd>Sarcoma</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec>
        <title>INTRODU&#xC7;&#xC3;O</title>
        <p>O angiossarcoma &#xE9; um tumor maligno com origem nas c&#xE9;lulas endoteliais vasculares ou linf&#xE1;ticas e representa aproximadamente 2% de todos os sarcomas de partes moles.<sup>(</sup>
<xref rid="B01" ref-type="bibr">1</xref>
<sup>)</sup> Os locais prim&#xE1;rios mais comuns s&#xE3;o a pele e o tecido subcut&#xE2;neo da cabe&#xE7;a e pesco&#xE7;o,<sup>(</sup>
<xref rid="B02" ref-type="bibr">2</xref>
<sup>)</sup> sendo o comprometimento pulmonar quase sempre metast&#xE1;tico. <sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>)</sup> O angiossarcoma pulmonar prim&#xE1;rio &#xE9; extremamente raro, havendo poucos casos relatados.</p>
      </sec>
      <sec>
        <title>RELATO DE CASO</title>
        <p>Mulher de 78 anos, n&#xE3;o tabagista, anteriormente avaliada por apresentar TC de t&#xF3;rax com massa pulmonar no lobo superior esquerdo (<xref ref-type="fig" rid="f1">Figura 1</xref>A). Na &#xE9;poca, foi submetida a broncoscopia com LBA e bi&#xF3;psias br&#xF4;nquicas, os quais foram negativos para tecido neopl&#xE1;sico. Posteriormente, abandonou o seguimento. Dois anos depois, foi encaminhada ao nosso hospital por dispneia, tosse seca e perda de peso com seis meses de evolu&#xE7;&#xE3;o. A radiografia e a TC de t&#xF3;rax (sem contraste) evidenciaram les&#xE3;o de 10 &#xD7; 7 cm em lobo superior esquerdo, sem plano de clivagem com a aorta e a art&#xE9;ria pulmonar (Figuras 1B e 1C), com pequeno derrame pleural &#xE0; esquerda e pequenos linfonodos mediastinais. A tomografia por emiss&#xE3;o de p&#xF3;sitrons com <sup>18</sup>F fluordesoxiglicose combinada &#xE0; TC (FDG PET-CT, do ingl&#xEA;s <italic>18F-fluorodeoxyglucose positron emission tomography-CT</italic>, <xref ref-type="fig" rid="f1">Figura 1</xref>D) mostrou aumento de atividade metab&#xF3;lica em v&#xE1;rios &#xF3;rg&#xE3;os, nomeadamente na massa do lobo superior esquerdo que apresentava o valor padronizado de capta&#xE7;&#xE3;o (SUV, do ingl&#xEA;s <italic>standardized uptake value</italic>) m&#xE1;ximo (SUVm&#xE1;x) de 22. Outros s&#xED;tios envolvidos foram os linfonodos mediastinais (SUVm&#xE1;x = 7), as gl&#xE2;ndulas adrenais direita e esquerda (SUVm&#xE1;x = 16), os linfonodos a&#xF3;rticos lombares (SUVm&#xE1;x = 11) e o linfonodo inguinal direito (SUVm&#xE1;x = 10). Documentou-se ainda, um foco mesent&#xE9;rico, n&#xF3;dulos no tecido subcut&#xE2;neo e extensa metastatiza&#xE7;&#xE3;o &#xF3;ssea.</p>
        <p>
<fig id="f1" orientation="portrait" position="float"><label>Figura 1.</label><caption><title>Evolu&#xE7;&#xE3;o do angiossarcoma em mulher de 78 anos, n&#xE3;o tabagista: em A, TC de t&#xF3;rax inicial mostrando massa pulmonar em lobo superior esquerdo; em B e C, TCs de t&#xF3;rax, obtidas dois anos depois, mostrando les&#xE3;o de 10 &#xD7; 7 cm em lobo superior esquerdo, com pequeno derrame pleural &#xE0; esquerda e pequenos linfonodos mediastinais; em D, tomografia por emiss&#xE3;o de p&#xF3;sitrons com <sup>18</sup>F fluordesoxiglicose combinada &#xE0; TC mostrando aumento de atividade metab&#xF3;lica em muitos &#xF3;rg&#xE3;os, maior na massa no lobo superior esquerdo.</title></caption><graphic xlink:href="1806-3713-jbpneu-42-01-00068-gf01-pt"/></fig>
</p>
        <p>O exame broncosc&#xF3;pico revelou massa ocluindo o br&#xF4;nquio lobar superior esquerdo (<xref ref-type="fig" rid="f2">Figura 2</xref>), e foram realizadas bi&#xF3;psias por broncoscopia. Antes da obten&#xE7;&#xE3;o dos resultados do exame da amostra de tecido, a paciente desenvolveu hemiparesia &#xE0; direita e houve aparecimento de novo n&#xF3;dulo subcut&#xE2;neo cervical. A TC de cr&#xE2;nio mostrou m&#xFA;ltiplas les&#xF5;es cerebrais, e a paciente iniciou tratamento com corticosteroides. Por&#xE9;m, n&#xE3;o houve melhora cl&#xED;nica, e foi proposta radioterapia cerebral.</p>
        <p>
<fig id="f2" orientation="portrait" position="float"><label>Figura 2.</label><caption><title>Fotografia de uma massa ocluindo o br&#xF4;nquio lobar superior esquerdo.</title></caption><graphic xlink:href="1806-3713-jbpneu-42-01-00068-gf02-pt"/></fig>
</p>
        <p>O exame histol&#xF3;gico da bi&#xF3;psia mostrou neoplasia de partes moles com arranjo laminar, ou em forma de fenda circundante, formada por c&#xE9;lulas fusiformes e epitelioides com nucl&#xE9;olos proeminentes, com alguma multinuclea&#xE7;&#xE3;o; eram evidentes figuras mit&#xF3;ticas, extensa necrose e hemorragia (<xref ref-type="fig" rid="f3">Figura 3</xref>A). A colora&#xE7;&#xE3;o imuno-histoqu&#xED;mica do fragmento tumoral revelou que esse era fortemente positivo para CD31 (<xref ref-type="fig" rid="f3">Figura 3</xref>B), ant&#xED;geno relacionado ao fator VIII (<xref ref-type="fig" rid="f3">Figura 3</xref>C) e vimentina; fracamente positivo para fator de transcri&#xE7;&#xE3;o nuclear Fli-1 e citoqueratinas AE1/AE3; e negativo para CD34, desmina e actina de m&#xFA;sculo liso. Portanto, a histologia e a imuno-histoqu&#xED;mica foram compat&#xED;veis com angiossarcoma epitelioide.</p>
        <p>
<fig id="f3" orientation="portrait" position="float"><label>Figura 3.</label><caption><title>Exame histol&#xF3;gico da bi&#xF3;psia: em A, extensa necrose e hemorragia; em B, colora&#xE7;&#xE3;o imuno-histoqu&#xED;mica para CD31; em C, colora&#xE7;&#xE3;o imuno-histoqu&#xED;mica para o ant&#xED;geno relacionado ao fator VIII.</title></caption><graphic xlink:href="1806-3713-jbpneu-42-01-00068-gf03-pt"/></fig>
</p>
        <p>Duas semanas ap&#xF3;s o diagn&#xF3;stico histol&#xF3;gico, a paciente morreu. Sua morte foi atribu&#xED;da &#xE0; progress&#xE3;o da doen&#xE7;a, em particular &#xE0;s met&#xE1;stases cerebrais.</p>
      </sec>
      <sec>
        <title>DISCUSS&#xC3;O</title>
        <p>O angiossarcoma no pulm&#xE3;o geralmente representa met&#xE1;stase de outro s&#xED;tio prim&#xE1;rio. Contudo, acreditamos que o caso aqui descrito foi de angiossarcoma pulmonar prim&#xE1;rio. A paciente apresentava massa pulmonar, com mais de dois anos de evolu&#xE7;&#xE3;o, que n&#xE3;o havia sido monitorada nem tratada. Parece-nos evidente que a les&#xE3;o anterior correspondia ao angiossarcoma pulmonar que evoluiu e se disseminou durante esse per&#xED;odo. Este relato de caso tamb&#xE9;m documenta o comportamento do angiossarcoma pulmonar prim&#xE1;rio, que se caracteriza por um crescimento insidioso com extensa invas&#xE3;o local e met&#xE1;stase hematog&#xEA;nica.<sup>(4) </sup>O seu diagn&#xF3;stico precoce n&#xE3;o &#xE9; frequente, tendo em conta a sua raridade e o baixo &#xED;ndice de suspei&#xE7;&#xE3;o. De acordo com dados da literatura, a m&#xE9;dia de idade dos pacientes com angiossarcoma pulmonar &#xE9; de 55,9 anos (varia&#xE7;&#xE3;o, 23,0-82,0 anos) e o sexo masculino &#xE9; mais acometido do que o feminino.<sup>(</sup>
<xref rid="B05" ref-type="bibr">5</xref>
<sup>)</sup> Os pacientes geralmente apresentam sintomas respirat&#xF3;rios inespec&#xED;ficos que incluem hemoptise, tosse, dispneia, dor tor&#xE1;cica e perda de peso. Na TC, o angiossarcoma prim&#xE1;rio pode ser multifocal ou se manifestar como les&#xF5;es solit&#xE1;rias. <sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">6</xref>
<sup>,</sup>
<xref rid="B07" ref-type="bibr">7</xref>
<sup>)</sup> A PET pode ser &#xFA;til no diagn&#xF3;stico, estadiamento<sup>(</sup>
<xref rid="B08" ref-type="bibr">8</xref>
<sup>)</sup> e seguimento de pacientes com angiossarcoma.<sup>(</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>)</sup> No caso aqui descrito, a FDG PET-CT confirmou sua utilidade na identifica&#xE7;&#xE3;o do envolvimento sist&#xEA;mico.</p>
        <p>A bi&#xF3;psia e a an&#xE1;lise imuno-histoqu&#xED;mica s&#xE3;o essenciais para o diagn&#xF3;stico de angiossarcoma. As caracter&#xED;sticas histol&#xF3;gicas podem variar dentro e entre os casos. C&#xE9;lulas endoteliais pleom&#xF3;rficas anormais e malignas constituem a principal caracter&#xED;stica do angiossarcoma. Essas c&#xE9;lulas podem ser arredondadas, poligonais ou fusiformes, com ou sem apar&#xEA;ncia epitelioide. Em &#xE1;reas bem diferenciadas, as c&#xE9;lulas endoteliais anormais formam canais vasculares sinusoides funcionais em continuidade com canais vasculares normais. Em pacientes com doen&#xE7;a progressivamente mais agressiva, a arquitetura torna-se mais ca&#xF3;tica, com espa&#xE7;os vasculares menos claramente definidos. Em &#xE1;reas pouco diferenciadas, as c&#xE9;lulas endoteliais malignas formam monocamadas cont&#xED;nuas, geralmente com morfologia epitelioide. O angiossarcoma tipicamente expressa marcadores endoteliais que incluem ant&#xED;geno relacionado ao fator VIII, CD34, CD31 e Fli-1. Entre esses marcadores, o ant&#xED;geno relacionado ao fator VIII &#xE9; o mais espec&#xED;fico, mas o menos sens&#xED;vel. A positividade para CD31 &#xE9; relativamente espec&#xED;fica e extremamente sens&#xED;vel, sendo detectada em aproximadamente 90% dos casos. Em aproximadamente 30% dos casos, o angiossarcoma expressa citoqueratina.<sup>(</sup>
<xref rid="B10" ref-type="bibr">10</xref>
<sup>)</sup>
</p>
        <p>Tendo em considera&#xE7;&#xE3;o a raridade do angiossarcoma, n&#xE3;o h&#xE1; um esquema terap&#xEA;utico padr&#xE3;o estabelecido, especialmente para o angiossarcoma pulmonar prim&#xE1;rio. De acordo com os relatos de caso descritos, os doentes com angiossarcoma pulmonar t&#xEA;m sido tratados com radioterapia,<sup>(</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>,</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>)</sup> ressec&#xE7;&#xE3;o cir&#xFA;rgica,<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>)</sup> imunoterapia,<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">6</xref>
<sup>,</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>)</sup> quimioterapia,<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">6</xref>
<sup>,</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>)</sup> ou uma combina&#xE7;&#xE3;o dessas modalidades.<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">6</xref>
<sup>,</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>,</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>)</sup>
</p>
        <p>Embora nenhuma dessas abordagens se tenha mostrado eficaz de forma consistente, h&#xE1; descri&#xE7;&#xF5;es de resposta com algumas dessas op&#xE7;&#xF5;es terap&#xEA;uticas,<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>,</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>)</sup> especialmente em casos de doen&#xE7;a localizada. A cirurgia tem sido proposta como o tratamento mais eficaz, devendo ser considerada o mais cedo poss&#xED;vel no caso de tumores ressec&#xE1;veis.<sup>(</sup>
<xref rid="B05" ref-type="bibr">5</xref>
<sup>)</sup> Contudo, a sua interven&#xE7;&#xE3;o encontra-se limitada, tendo em conta que a maioria dos casos s&#xE3;o inoper&#xE1;veis na data do diagn&#xF3;stico. A terapia multimodal, tal como a combina&#xE7;&#xE3;o de radioterapia e imunoterapia (interleucina-2 recombinante)<sup>(</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>)</sup> e a de cirurgia e quimioterapia,<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>)</sup> tem se mostrado eficaz. H&#xE1; relatos de que a quimioterapia com gemcitabina e docetaxel produz uma resposta radiogr&#xE1;fica completa.<sup>(</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>)</sup>
</p>
        <p>O progn&#xF3;stico do angiossarcoma pulmonar &#xE9; mau, sendo a mortalidade nos primeiros meses ap&#xF3;s a apresenta&#xE7;&#xE3;o cl&#xED;nica, como no caso aqui descrito, de aproximadamente 100%.<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>-</sup>
<xref rid="B07" ref-type="bibr">7</xref>
<sup>)</sup>
</p>
        <p>Em conclus&#xE3;o, o angiossarcoma &#xE9; uma neoplasia maligna rara, havendo apenas algumas dezenas de casos de angiossarcoma pulmonar prim&#xE1;rio relatados na literatura. Apesar de representar um desafio diagn&#xF3;stico para cl&#xED;nicos e anatomopatologistas, &#xE9; essencial um elevado &#xED;ndice de suspei&#xE7;&#xE3;o para o seu diagn&#xF3;stico precoce e, possivelmente, melhor progn&#xF3;stico.</p>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn id="fn1" fn-type="other">
          <p>Trabalho realizado no Centro Hospitalar Lisboa Norte, EPE, Lisboa, Portugal.</p>
        </fn>
        <fn id="fn2" fn-type="supported-by">
          <p>Apoio financeiro: Nenhum.</p>
        </fn>
      </fn-group>
    </back>
  </sub-article>
</article>
</pmc-articleset>
